Angiodynamics (ANGO) Change in Receivables (2010 - 2026)

Angiodynamics (ANGO) has reported Change in Receivables for 17 consecutive years, with $2.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Receivables rose 749.44% year-over-year to $2.9 million; the trailing twelve-month figure through May 2026 stood at $5.8 million (up 25100.0% YoY), and the FY2026 full-year result was $5.8 million, up 25100.0% from the prior year.
• Change in Receivables rose to $2.9 million in Q2 2026 per ANGO's latest filing, from $1.4 million in the prior quarter.
• Across five years, Change in Receivables topped out at $10.7 million in Q2 2022 and bottomed at -$5.5 million in Q2 2024.
• Historically, Change in Receivables has averaged $742277.8 across 5 years, with a median of $946000.0 in 2025.
• The sharpest annual moves came in 2022 and 2024: Change in Receivables jumped 3858.33% in 2022, then slumped 369.63% in 2024.
• Over 5 years, Change in Receivables stood at -$406000.0 in 2022, then soared by 710.84% to $2.5 million in 2023, then soared by 50.56% to $3.7 million in 2024, then sank by 58.01% to $1.6 million in 2025, then surged by 85.14% to $2.9 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered $2.9 million, $1.4 million, and $1.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.